Vivos Therapeutics, Inc. (VVOS)
0.8424
-0.05
(-5.97%)
USD |
NASDAQ |
Apr 24, 16:00
0.8422
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics EPS Diluted (Quarterly) : -0.7424 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acurx Pharmaceuticals, Inc. | -0.6722 |
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Abeona Therapeutics, Inc. | -0.3717 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.954M |
| Revenue (Quarterly) | 3.824M |
| Total Expenses (Quarterly) | 10.72M |
| Enterprise Value | 22.77M |
| Gross Profit Margin (Quarterly) | 66.58% |
| Profit Margin (Quarterly) | -181.9% |
| Earnings Yield | -265.4% |
| Normalized Earnings Yield | -265.44 |